Pulse Explore Journal Club Debates Trending Researchers Journals

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Home Explore Journal Club Trending

⌘+K

Monoclonal Antibodies for Emerging Infectious Diseases — Borrowing from History | Synapse

March 7, 2018New England Journal of Medicine130 citations

View Full Paper

Monoclonal Antibodies for Emerging Infectious Diseases — Borrowing from History

HMHilary D. MarstonUnited States Food and Drug Administration CPCatharine I. PaulesPenn State Milton S. Hershey Medical Center

Anthony S. FauciGeorgetown University

Key Points

Key points are not available for this paper at this time.

Abstract

Interview with Dr. Anthony Fauci on the use of monoclonal antibodies in the context of emerging infectious diseases. (09:25)Download Research advances could facilitate use of monoclonal antibodies for emerging infectious diseases — in treatment of infected individuals, targeted prophylaxis to protect high-risk individuals, and targeted prophylaxis to interrupt transmission in average-risk populations.

Ask AI

Helpful

Bookmark

Share

View Full Paper

Ask AI

Helpful

Bookmark

Share

View Full Paper

Cite This Study

Marston et al. (Wed,) studied this question.

synapsesocial.com/papers/6a6d888b35aa2c282cdfeff5 https://doi.org/https://doi.org/10.1056/nejmp1802256